Skip to main content
Clinical Trials/ACTRN12624001025527
ACTRN12624001025527Not yet recruitingUnknown

Redefining Glucose Thresholds for Hypoglycaemia Management in Children with Type 1 Diabetes on Closed Loop Therapy: A Cross-over Clinical Trial

Perth Children's Hospital0 sites40 target enrollmentStarted: August 23, 2024Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
6 Years to 18 Years (—)
Sex
All

Inclusion Criteria

  • 1.Diagnosis of Type 1 diabetes
  • 2.6 to 18 years
  • 3.Duration of diabetes of >12 months
  • 4.On advanced closed loop therapy
  • 4.1for at least 4 weeks and
  • 4.2using the system optimally for >80% in last 2 weeks.

Exclusion Criteria

  • 1.Impaired hypoglycaemia awareness. Self-reported Gold score greater than or equal to 4 (these patients need higher glucose targets). For young children (age 6 to 10 years or if the child is developmentally young to self-report), parent-reported response will be used.
  • 2.Increased time spent in hypoglycaemia as documented on CGM (>2% of time spent <3.0 mmol/L and/or >6% of time spent <3.9 mmol/L) for last two weeks
  • 3.Families not willing to try lower cut-off due to fear of hypoglycaemia.
  • 4.Severe hypoglycaemia (coma, convulsion or altered consciousness requiring third party assistance) in last 12 months.
  • 5.Any medical or psychological disease state of the child and/or caregiver that limits capacity to participate in the study.

Investigators

Sponsor
Perth Children's Hospital

Similar Trials